Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

Recent studies have shown that high-risk patients with type 2 diabetes mellitus (T2DM) treated with sodium glucose cotransporter 2 (SGLT2) inhibitors have improved cardiovascular (CV) outcomes. In an exploratory analysis of data from the EMPA-REG study, elevations in haematocrit were shown to be str...

Descripción completa

Detalles Bibliográficos
Autores principales: Aberle, Jens, Menzen, Markus, Schmid, Sebastian M., Terkamp, Christoph, Jaeckel, Elmar, Rohwedder, Katja, Scheerer, Markus F., Xu, John, Tang, Weifeng, Birkenfeld, Andreas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769973/
https://www.ncbi.nlm.nih.gov/pubmed/33372185
http://dx.doi.org/10.1038/s41598-020-78734-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769973/
https://www.ncbi.nlm.nih.gov/pubmed/33372185
http://dx.doi.org/10.1038/s41598-020-78734-z

Ejemplares similares